您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:医思健康2024/25 半年度业绩报告 - 发现报告

医思健康2024/25 半年度业绩报告

2024-12-20港股财报「***
AI智能总结
查看更多
医思健康2024/25 半年度业绩报告

Contents目錄 Corporate Information公司資料2Geographical Coverage地域覆蓋4Financial Highlights財務摘要5Management Discussion and Analysis管理層討論及分析7Other Information其他資料26Consolidated Statement of Profit orLoss and Other Comprehensive Income綜合損益及其他全面收益表40Consolidated Statement ofFinancial Position綜合財務狀況表41Consolidated Statement ofChanges in Equity綜合權益變動表43Condensed Consolidated Statement ofCash Flows簡明綜合現金流量表44Notes to the Interim Financial Statements中期財務報表附註45Definitions釋義70 Corporate Information公司資料 DIRECTORS 董事 執行董事 Executive Directors TANG Chi Fai(Chairman)LU Lyn Wade Leslie(Chief Executive Officer)LEE Heung Wing(Chief Financial Officer) 鄧志輝(主席)呂聯煒(行政總裁)李向榮(首席財務官) 非執行董事陸韵晟(資訊科技總監) Non-Executive DirectorLUK Kun Shing Ben(Chief Information Officer) 獨立非執行董事 Independent Non-Executive Directors MA Ching NamLOOK AndrewAU Tsun 審核委員會陸東(主席)馬清楠區雋 AUDIT COMMITTEE LOOK Andrew(Chairman)MA Ching NamAU Tsun NOMINATION COMMITTEE 提名委員會鄧志輝(主席)陸東區雋 TANG Chi Fai(Chairman)LOOK AndrewAU Tsun REMUNERATION COMMITTEE 薪酬委員會 區雋(主席)馬清楠陸東 AU Tsun(Chairman)MA Ching NamLOOK Andrew 公司秘書蕭鎮邦 COMPANY SECRETARYSIU Chun Pong Raymond 授權代表李向榮蕭鎮邦 AUTHORISED REPRESENTATIVES LEE Heung WingSIU Chun Pong Raymond 股份代號2138 STOCK CODE2138 公司網站www.echealthcare.com COMPANY’S WEBSITEwww.echealthcare.com Corporate Information公司資料 PRINCIPAL SHARE REGISTRAR ANDTRANSFER OFFICE 主要證劵登記處 Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman Islands Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman Islands 香港證券登記處 HONG KONG SHARE REGISTRAR Link Market Services (Hong Kong) Pty LimitedSuite 1601, 16/F, Central Tower28 Queen’s Road CentralHong Kong Link Market Services (Hong Kong) Pty Limited香港皇后大道中28號中匯大廈16樓1601室 REGISTERED OFFICE 註冊辦事處 Cricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman Islands Cricket Square, Hutchins DrivePO Box 2681, Grand Cayman KY1-1111Cayman Islands 香港總部及主要營業地點 HEADQUARTERS AND PRINCIPAL PLACE OFBUSINESS IN HONG KONG 20/F, Devon HouseTaikoo Place979 King’s RoadQuarry BayHong Kong 香港鰂魚涌英皇道979號太古坊德宏大廈20樓 LEGAL ADVISER 法律顧問 As to Hong Kong lawRaymond Siu & LawyersUnits 1302–3 & 1802, Ruttonjee House11 Duddell StreetCentral, Hong Kong 香港法律蕭鎮邦律師行香港中環都爹利街11號律敦治大廈1302–3及1802室 As to PRC LawZhong Lun Law Firm8–10/F, Tower A, Rongchao Tower, 6003 Yitian Road,Futian District, Shenzhen 518026, P.R.China 中國內地法律中倫律師事務所中國深圳市福田區益田路6003號榮超商務中心A棟8–10層,郵編518026 核數師 AUDITOR 安永會計師事務所執業會計師公眾利益實體核數師香港鰂魚涌英皇道979號太古坊一座27樓 Ernst & YoungCertified Public AccountantsPublic Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong Geographical Coverage地域覆蓋 Financial Highlights財務摘要 Financial Highlights財務摘要 附註: 1.EBITDA equals earnings before interests, taxation, depreciation-ownedproperty, plant and equipment and amortisation. EBITDA is not a standardmeasure under HKFRS. The Company’s management believes that EBITDA,as a proxy of operating cash flow generated by the Group’s businesses,provide investors with useful supplementary information to assess theperformance of the Group. 1.息稅折舊及攤銷前之盈利等於未計利息、稅項、自有物業、廠房及設備折舊以及攤銷前的盈利。息稅折舊及攤銷前之盈利並非香港財務報告準則下的標準計量方法。本公司管理層認為,息稅折舊及攤銷前之盈利作為本集團業務所得經營現金流的代表,為投資者提供有用的補充資料,以評估本集團的表現。 The following table sets out the reconciliation of the EBITDA and profit beforetax for the periods indicated: 2.息稅折舊及攤銷前之盈利率等於期內未計利息、稅項、自有物業、廠房及設備折舊以及攤銷前的盈利除以總收入。 2.EBITDA Margin equals earnings before interests, taxation, depreciation-ownedproperty, plant and equipment and amortisation over total revenue of theperiod. 3.淨溢利率等於所示期間溢利除以同期的收入。 3.Net profit margin equals profit for the periods indicated divided by revenue forthe same period. Management Discussion and Analysis管理層討論及分析 BUSINESS REVIEW 業務回顧 The momentum of global and local economic recovery has sloweddown during the Interim Period of FY25, affected by economicuncertainties, high interest rates, and inflationary pressures.Consequently, the business environment for the healthcare industryin Hong Kong has remained both challenging and competitive. Localservice providers are facing increased operational costs while strivingto meet rising patient demands, all within a landscape marked bymarket volatility. Nevertheless, during the Interim Period of FY25, theGroup demonstrated remarkable resilience and adaptability, reflectingits strategic vision, operational excellence, and commitment tostakeholders. Although the Group experienced a decline in revenue, itis essential to emphasize the significant progress made in enhancingoperational effectiveness and efficiency. These improvements positionthe Group well for future growth, ensuring that it can navigatechallenges while continuing to deliver value to its stakeholders. 受經濟不確定因素、高利率及通脹壓力影響,二零二五財年中期期間全球及本地經濟復蘇勢頭放緩。因此,香港醫療保健行業的營商環境仍充滿挑戰與競爭。在市場波動局勢下,本地服務提供商在努力滿足不斷增長的患者需求,同時面臨經營成本增加。儘管如此,在二零二五財年中期期間,本集團展現卓越的毅力及適應能力,反映自身的戰略願景、卓越營運以及對持份者作出的承諾。儘管本集團收入下降,惟有必要強調